$1.730
-0.037 (-2.15%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BLRX Prediction & Forecast by Similar Chart Analysis
Alphio's BLRX stock price prediction model matches the current BioLine RX Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+0.41%). The 1-week path is $1.76 (+1.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioLine RX Ltd Stock?
BioLine RX Ltd is not a good buy right now due to its current price of $1.73, a very low RSI of 11.115 indicating oversold conditions, and a staggering 49.71% decline over the past year. The company also reported a widening net loss of $4.3 million in Q2 2026, which raises concerns about its financial health and sustainability.
BLRX stock price ended at $1.73 on Friday, after losing -2.15%
BioLine RX Ltd (BLRX) last closed at $1.73, losing -2.15%. These facts feed the 1-day and 1-week BLRX price prediction above.
Analyst Consensus
BioLine RX Ltd (BLRX): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
BioLine RX Ltd (BLRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BLRX, ranked by similarity.
Seasonality analysis for BLRX
Historically the probability of a positive November return for BLRX is 0.00%. January offers the highest probability of a positive month at 36.07%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BLRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.47 | $4.73 | $5.11 | +173.47% |
| Dec 2026 | $4.26 | $4.62 | $4.97 | +166.97% |
In 2026, BioLine RX Ltd (BLRX) is projected to range from $4.26 to $5.11.
BioLine RX Ltd 2026 monthly forecast
In Nov 2026, BioLine RX Ltd is projected to average $4.73, with a low of $4.47 and high of $5.11.
In Dec 2026, BioLine RX Ltd is projected to average $4.62, with a low of $4.26 and high of $4.97.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.